Home About Us Capabilities & Services Technology Portfolio Contact & RFP
What We Do ยท End-to-End Bioprocess Solutions

Core Capabilities & Services

Our integrated service model covers every critical stage โ€” from clone and process development through analytical validation, regulatory documentation, and commercial-scale manufacturing readiness.

Technology Transfer
Platform 01

Technology Transfer

Seamless handoff from R&D to GMP manufacturing โ€” including full documentation and regulatory support.

Key Deliverables
  • โ€” End-to-end R&D to GMP transfer
  • โ€” Process standardization & reproducibility
  • โ€” Regulatory filing documentation
Process Development
Platform 02

Process Development

Upstream and downstream optimization to maximize yield, purity, and consistency at every scale.

Key Deliverables
  • โ€” Fermentation & cell culture development
  • โ€” Purification and yield enhancement
  • โ€” Upstream & downstream optimization
Scale-Up & Commercialization
Platform 03

Scale-Up & Commercialization

Pilot-to-commercial transitions that protect process integrity and accelerate market entry.

Key Deliverables
  • โ€” Pilot to commercial scale transition
  • โ€” Techno-commercial feasibility studies
  • โ€” Manufacturing readiness assessment
Why Kovi

Built for Complex Biomanufacturing

01

Specialized in Biologics Technology Transfer

Our entire practice is built around the challenges of complex biologics โ€” not a side offering within a larger organization.

02

Expertise Across Microbial & Mammalian Platforms

We operate across both fermentation-based and mammalian cell culture systems, giving clients broader molecule coverage.

03

Focus on Scalability & GMP Readiness

Every process we develop is designed with commercial-scale and regulatory compliance in mind from day one.

04

Integrated Support: Clone โ†’ Process โ†’ Scale โ†’ Commercial

A single partner for the full development journey โ€” reducing handoff risk and keeping timelines on track.

05

Ideal Partner for Biosimilars, CDMOs & Biotech Startups

Whether you're developing a biosimilar or building a new biologics program, we adapt to your stage and scale.